Allergan vs BeiGene

Allergan vs BeiGene, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Allergan is on 19/100 and BeiGene on 64/100.

Allergan logo
AllerganA global pharmaceutical company focused on developing and marketing innovative treatments.
Try Allergan
BeiGene logo
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.
Try BeiGene

Where each one leads

Allergan

  • domain rating: 76/100 against 68/100
  • funding raised: $30B against $358M

BeiGene

  • our overall score: 64/100 against 19/100
  • agent readiness: 50/100 against 25/100

At a glance

MeasureAllerganBeiGene
What it isA global pharmaceutical company focused on developing and marketing innovative treatments.A global oncology company developing and commercializing innovative cancer treatments.
CategoryBiotech, MedTech, HealthTech, Drug DiscoveryBiotech, MedTech, HealthTech, Genomics
Sells toBusiness modelB2B | B2CB2B
OfferingPharmaceuticalsPlatform
Founded19482010
HeadquartersDublin, IrelandCambridge, United States
StatusActiveActive

Size, funding and growth

MeasureAllerganBeiGene
Open rolesNot published100
Total funding$30B$358M
Latest roundNot publishedSecondary Offering
ValuationNot published$15B

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAllerganBeiGene
StartupHub scoreOur 0-100 rating19/10064/100
Traction40/10040/100
TeamNot published30/100
Search visibility20/10017/100
Quality15/10088/100
Agent readinessHow well an AI agent can read and act on the siteF (25/100)D (50/100)
Domain ratingLink authority, 0-10076/10068/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAllerganBeiGene
CDNCloudflareCloudflare
CMSNot detectedWordPress
FrameworksTailwind CSSJquery, Tailwind CSS, Bootstrap

Allergan vs BeiGene: common questions

Which is better, Allergan or BeiGene?

On our 0-100 score BeiGene rates higher (64/100 against 19/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Allergan and BeiGene compare on the numbers?

Allergan leads on domain rating (76/100 against 68/100), funding raised ($30B against $358M). BeiGene leads on our overall score (64/100 against 19/100), agent readiness (50/100 against 25/100).

Read the full Allergan review and pricing or the BeiGene review and pricing. You can also browse other Allergan alternatives we track.